Advertisement

Chinese Journal of Cancer Research

, Volume 8, Issue 4, pp 263–266 | Cite as

Relationship between the mutation of P53 gene and infiltration, metastasis and prognosis of gastric carcinoma

  • Xin Yan 
  • Zhao Fengkai 
  • Wu Dongying 
  • Wang Yanping 
  • Xu Lei 
  • Zhang Yinchang 
  • Kristin Henry
Clinical Observations
  • 13 Downloads

Abstract

132 gastric carcinomas were examined immunohistochemically with McAb to p53 protein in order to investigate the relationship between the expression of p53 protein and histological differentiation of gastric carcinoma, and to approach the mechanism of infiltration and metastasis of gastric carcinoma. The results showed that nuclear expression of p53 protein was significantly related to tumor size, depth of invasion, lymph node and liver metastases; but not related to histological differentiation. It is suggested that the accumulation of p53 protein was increased with the progression of gastric carcinoma, and therefore the cancer clone with p53 gene mutation may play an important role in the development of tumor invasion and metastasis.

Key words

p53 gene Tumor suppresser gene Metastasis Gastric carcinoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Iggo R, et al. Increased expression of mutant forms of p53 oncogen nin primary lung cancer. Lancet 1990; 335: 675.PubMedCrossRefGoogle Scholar
  2. 2.
    Verly JM, et al. Loss of chromosomes 17p13 sequences and mutation of p53 in human carcinomas. Oncogene 1991; 6: 413.Google Scholar
  3. 3.
    Batek J, et al. Genetic and immunohistochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 1990; 5: 893.Google Scholar
  4. 4.
    Martin HM, et al. p53 expression and prognosis in gastric carcinoma. Int J Cancer 1992; 50: 859.PubMedCrossRefGoogle Scholar
  5. 5.
    Seruca R, et al. p53 mutatijons in gastric carcinomas. Br J Cancer 1992; 65: 708.PubMedGoogle Scholar
  6. 6.
    Norton AJ, et al. Brief high-temperature heat denaturation (Pressure Cooking): A simple and effective method of antigen retrival for routinely tissues. J Pathol 1994; 173: 371.PubMedCrossRefGoogle Scholar
  7. 7.
    Sidranskey D, et al. Identifications of p53 mutations in bladder cancer and urine samples. science 1991; 152: 706.CrossRefGoogle Scholar
  8. 8.
    Joypaul BV, et al. Enzyme-linked immunosorbent assay for p53 in gastrointestinal malignancy: comparison with immunohistochemistry. Histopathol 1993; 23: 465.CrossRefGoogle Scholar
  9. 9.
    Midgley CA, et al. Analysis of p53 expression in human tumors: an antibody ransed against human p53 expressed in E.coli. Cell Sci 1992; 101: 183.Google Scholar
  10. 10.
    Craven JL, et al. Radical surgery for gastric cancer. In: Preece PE, et al. eds. Cancer of the stomach. London: Grune and stratton. 1986; 165–188.Google Scholar
  11. 11.
    Adeshek K, et al. Cancer of the stomach. Review of consecutive ten-year intervals. Ann Surg 1979; 186: 6.CrossRefGoogle Scholar
  12. 12.
    Meyer HJ, et al. Patterns of recurrence in relation to the rapeutic strategy in gastric cancer. Scand J Gastroenterol 1987; 22 (Suppl 133): 45.CrossRefGoogle Scholar
  13. 13.
    Rohde H, et al. What causes in-hospital mortality of surgical patients with cancer of the stomach? Scand J Gastroenterol 1987; 22 (Suppl 133): 76.CrossRefGoogle Scholar
  14. 14.
    Remine WH, et al. Long-term survival (10 to 56 years) after surgery for carcinoma of the stomach. Am J Surg 1969; 117: 177.PubMedCrossRefGoogle Scholar
  15. 15.
    Korenaga D, et al. Long-term survival in Japanese patients with far advanced carcinoma of the stomach. World J Surg 1988; 12: 236.PubMedCrossRefGoogle Scholar
  16. 16.
    Zhang YC, et al. Precancerous conditions and lesions of the stomach. Springer-Verlag, Heideberg 1993; 1.Google Scholar
  17. 17.
    Hall PA, et al. High levels of p53 protein in UV-irradiated normal human skin. Oncogen 1993; 8L 203.Google Scholar

Copyright information

© Chinese Journal Of Cancer Research 1996

Authors and Affiliations

  • Xin Yan 
    • 1
  • Zhao Fengkai 
    • 1
  • Wu Dongying 
    • 1
  • Wang Yanping 
    • 1
  • Xu Lei 
    • 1
  • Zhang Yinchang 
    • 1
  • Kristin Henry
    • 2
  1. 1.Cancer InstituteChina Medical UniversityShenyang
  2. 2.Department of Histopathology, Charring Cross & Westminster Medical SchoolUniversity of LondonUK

Personalised recommendations